In July 2021, the Indonesian Food and Drug Monitoring Agency (BPOM) finally granted the Emergency Use Authorization for Ivermectin as the therapeutic drug to cure the Covid-19.
This was due to the country’s “worst-case scenario” epidemic at the time according to officials.
Indonesia experienced a spike in COVID-19 infection and deaths in July and was struggling to slow the virus transmission due to its high population. Indonesia is ranked as the world’s fourth most populous country.
The government imposed an emergency measure to slow the spread of the virus. One of its measures was to authorize the use of Ivermectin as a COVID-19 treatment.
The Strait Times reported:
The Indonesian government on Thursday (July 15) began distributing free medicine and vitamins to self-isolating Covid-19 patients in high-risk areas as the highly transmissible Delta variant of the coronavirus continued to rip through the country, emptying pharmacy shelves.
Each package will have seven days worth of therapeutic Covid-19 drugs and vitamins, and will be given to asymptomatic patients as well as those with mild to moderate symptoms including fever and dry cough. The medication for the latter group will require consultation with a doctor and a prescription.
Medical facilities are stretched thin, and demand for oxygen and medication has also soared. As scores of people are isolating themselves at home and self-medicating, prices of drugs have shot up in pharmacies and online. The health ministry has since moved to cap the prices of drugs such as favipiravir, remdesivir and ivermectin.
Indonesia’s food and drug agency has authorised ivermectin for emergency use against Covid-19, Reuters reported, although the World Health Organisation, as well as European and the US regulators did not recommend its use for Covid-19 patients.
After the government authorized the use of Ivermectin for COVID-19 patients, the number of cases significantly plummeted since July.
The data below proves that Ivermectin played a major role on the steep decline of COVID-19 cases despite having a low vaccination rate.
Here is an article on how India defeated the delta variant of Covid with Ivermectin. In the state of Uttar Pradesh 33 districts declared themselves free from COVID-19 on September 7. Only the district of Agra has lingering outbreaks, probably because it is the home of Taj Mahal and with it the large influx of people from all over the world visiting the area. The statistics for all of India looks like this today:
How does the U.S. A. compare? Indonesia has a population of about 275 million people, the population of India is about 1,400 million and USA’s is about 330 million.The delta variant of COVID hit first in India, spread to Indonesia, and hit the USA in August. India took decisive early action, Indonesia followed. USA has yet to consider remedies.
The statistics are staggering. Indonesia has a current daily death rate of 0,28 per million, India’s rate is 0.18 per million and the current daily death rate from COVID-19 in the U.S.A. is 21.1 per million, 75 times worse than Indonesia and 117 times worse than India. And we are supposed to have a better health care system!
If our esteemed bureaucrats in CDC and NIH would consider the people they would have approved Ivermectin, HydroCloroQuine and a few other working cures rather than only approve medicine that has undergone double blind trials through paying manufacturers, willing and able to charge for the medicines. If they were to consider proven generics the same we the people could have saved at least 5,000 lives a day just from Ivermectin alone.